Imagion Biosystems

0.008

0.000

成交量：136.25萬

成交額：1.09萬

市值：640.81萬

市盈率：-0.73

高：0.008

開：0.008

低：0.008

收：0.008

52周最高：0.055

52周最低：0.007

股本：8.01億

流通股本：1.72億

量比：0.52

換手率：0.79%

股息：- -

股息率：- -

每股收益(TTM):-0.011

每股收益(LYR):-0.016

淨資產收益率：-2804.87%

總資產收益率：-319.68%

市淨率：-1.87

市盈率(LYR):-0.52

資料載入中...

總覽公司新聞資訊公告

Imagion Biosystems獲FDA二期臨床試驗許可後成功融資375萬澳元

美股速递

·

06/25

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IBX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.008,"timestamp":1789539120000,"preClose":0.008,"halted":0,"volume":1362500,"delay":0,"changeRate":0,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":801006908,"eps":-0.010968,"marketStatus":"已收盤","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.008,"high":0.008,"low":0.008,"amount":10900,"amplitude":0,"askPrice":0.009,"askSize":3853874,"bidPrice":0.008,"bidSize":208897,"shortable":3,"etf":0,"ttmEps":-0.010968,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.008,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.515527,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IBX.AU","preClose":0.008,"auctionPrice":0.008,"auctionVolume":21428,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452000357}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-319.68%","roe":"-2804.87%","lyrEps":-0.01553,"volumeRatio":0.515527,"shares":801006908,"dividePrice":0,"high":0.008,"amplitude":0,"preClose":0.008,"low":0.008,"week52Low":0.007,"pbRate":"-1.87","psRate":"11.18","week52High":0.055,"institutionHeld":0,"latestPrice":0.008,"committee":-0.897165,"eps":-0.010968,"divideRate":0,"volume":1362500,"delay":0,"ttmEps":-0.010968,"open":0.008,"prevYearClose":0.025,"prevWeekClose":0.008,"prevMonthClose":0.008,"prevQuarterClose":0.011,"fiveDayClose":0.008,"twentyDayClose":0.01,"sixtyDayClose":0.015,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185697396","title":"Imagion Biosystems獲FDA二期臨床試驗許可後成功融資375萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185697396","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185697396?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 23:52","pubTimestamp":1782402734,"startTime":"0","endTime":"0","summary":"在获得美国食品药品监督管理局（FDA）对其二期临床试验的许可后，Imagion Biosystems成功完成了375万澳元的资本募集。这一进展为公司的临床研究计划注入了关键资金，标志着其在医疗技术开发领域迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}